ArticleFrontiers in endocrinology2026
Hemoglobin-albumin-lymphocyte-platelet score associated with diabetic foot severity, unlike modified systemic immune-inflammatory index and modified systemic inflammatory response index.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Accurate evaluation of diabetic foot severity and prompt intervention is expected to improve patient prognosis. Systemic inflammatory response and nutritional metabolic status play important roles in the progression of diabetic foot. The purpose of this study was to investigate the relationship between the hemoglobin-albumin-lymphocyte-platelet (HALP) score, modified systemic immune-inflammatory index (mSII), modified systemic inflammatory response index (mSIRI) and diabetic foot severity. Methods: A total of 367 diabetic foot patients were retrospectively enrolled, and divided into mild diabetic foot group (Wagner grade 0-2)(n=239) and severe diabetic foot group (Wagner grade 3-5)(n=128). Clinical baseline data and laboratory examination data of the patients were collected, and the HALP score, mSII and mSIRI were calculated. The differences in HALP score, mSII and mSIRI between patients with mild and severe diabetic foot were compared. Logistic regression analysis was performed to explore the associations of HALP score, mSII and mSIRI with severe diabetic foot. Results: The severe diabetic foot group had significantly higher levels of mSII ( Conclusions: The HALP score correlates with diabetic foot severity and can be used as a potential reference indicator for evaluating the severity of diabetic foot; mSII and mSIRI are not associated with the severity of diabetic foot.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.